Clinical Effects of Intermitent Continuous Glucose Monitoring in Type 1 Diabetes

NCT05095610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1121

Last updated 2022-07-19

No results posted yet for this study

Summary

Observational cross-sectional multicenter study about clinical effect of intermitent continuous glucose monitoring (Flash) in adult type 1 diabetes patients in an Spanish public health system.

Conditions

Interventions

DEVICE

Flash

Use of the device FreeStyle Libre, only commercialized system for intermitent continuous glucose monitoring.

Sponsors & Collaborators

  • Castilla-La Mancha Health Service

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-03-30
Completion
2022-05-06
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05095610 on ClinicalTrials.gov